A detailed history of Tocqueville Asset Management L.P. transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 705,214 shares of CSBR stock, worth $5.72 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
705,214
Previous 684,628 3.01%
Holding current value
$5.72 Million
Previous $3.54 Million 2.97%
% of portfolio
0.05%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.95 - $5.14 $81,314 - $105,812
20,586 Added 3.01%
705,214 $3.43 Million
Q1 2024

May 09, 2024

BUY
$4.9 - $6.91 $245 - $345
50 Added 0.01%
684,628 $3.35 Million
Q4 2023

Feb 12, 2024

BUY
$4.56 - $6.59 $87,323 - $126,198
19,150 Added 2.88%
684,578 $3.85 Million
Q1 2023

May 10, 2023

BUY
$4.0 - $4.67 $200,800 - $234,434
50,200 Added 8.16%
665,428 $2.68 Million
Q4 2022

Feb 09, 2023

BUY
$3.75 - $7.69 $1.03 Million - $2.1 Million
273,562 Added 80.07%
615,228 $2.77 Million
Q3 2022

Nov 10, 2022

BUY
$7.21 - $9.47 $396,946 - $521,370
55,055 Added 19.21%
341,666 $2.56 Million
Q2 2022

Aug 12, 2022

BUY
$6.81 - $8.31 $232,561 - $283,786
34,150 Added 13.53%
286,611 $2.29 Million
Q1 2020

May 15, 2020

BUY
$4.19 - $8.62 $200,671 - $412,837
47,893 Added 23.41%
252,461 $1.87 Million
Q4 2019

Jan 14, 2020

BUY
$5.12 - $8.33 $358,400 - $583,100
70,000 Added 52.02%
204,568 $1.7 Million
Q3 2019

Oct 31, 2019

BUY
$5.4 - $8.99 $297,000 - $494,450
55,000 Added 69.12%
134,568 $760,000
Q4 2018

Feb 08, 2019

SELL
$7.29 - $15.27 $72,900 - $152,700
-10,000 Reduced 11.16%
79,568 $621,000
Q3 2018

Nov 13, 2018

SELL
$5.82 - $17.47 $147,729 - $443,441
-25,383 Reduced 22.08%
89,568 $1.57 Million
Q2 2018

Aug 13, 2018

BUY
$3.6 - $7.27 $413,823 - $835,693
114,951 New
114,951 $729,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $110M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.